This segment encompasses the core operations of Tibet Rhodiola Pharmaceutical Holding Co., focusing on the production of a diverse range of pharmaceutical products. It includes the manufacturing of capsules, biological preparations, granules, film coatings, and other formulations. The company leverages advanced manufacturing technologies and adheres to stringent quality control standards to ensure the efficacy and safety of its products. This segment is critical for meeting the growing demand for pharmaceuticals in both domestic and international markets, contributing significantly to the company's revenue and market presence. Future opportunities include expanding production capacity and adopting innovative manufacturing processes to enhance efficiency and reduce costs.

The Pharmaceutical Trading segment is responsible for the distribution and sale of the company's manufactured products. This involves establishing and maintaining a robust supply chain network, managing relationships with distributors and retailers, and implementing effective marketing strategies to promote product awareness and sales. The segment focuses on expanding market reach, both within China and internationally, and ensuring timely delivery of products to meet customer demand. Key activities include market analysis, sales forecasting, and customer relationship management. Future growth opportunities lie in leveraging e-commerce platforms and expanding into new geographic markets to increase sales volume and market share.